Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Former science editor for POZ
HIVers have more than almost anyone else.
A blood test that measures mitochondrial damage before it causes serious symptoms might one day serve as a crystal ball for HIVers on...
“Hit early, hit hard” was yesterday’s HAART mantra.
Resistance was all the rage at one of the year’s top AIDS research meetings -- but five new livers stole the show.
What’s old just might be new again if Nancy Padian, PhD, has her way.
Fears of future ticker trouble may put atazanavir, Bristol-Myers Squibb’s new once-daily protease inhibitor (PI), on the top of many HIVers’
Mirror, mirror, on the wall, who’s the cheekiest of us all? Lark Lands on the new “sugar” shots for facial wasting.
As Chardelle Lassiter asks The Big Question (to HAART or not), she demands that doc r-e-s-p-e-c-t her choice.
A complex mix of symptoms and a shrinking number of aids physicians can add up to an OI (opportunistic infection) ID crapshoot.
Conference on Retroviruses and Opportunistic Infections
This just in: Kissing can spread the virus that causes Kaposi’s sarcoma. But is the news’ bark worse than its bite?
A new test of drug levels in the blood is a must-have to make the most of your regimen.
Lymphoma is in the stars for more and more longtime HIVers. It’s an immune-cell thing.
HAART or heart disease? Plug your numbers into this fancy formula, grind a crank, and the answer flies out all over the chalkboard.
Tips for anyone undergoing radiation or chemotherapy
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.